KOLOA, Hawaii ― At Hawaiian Eye 2017, Jack T. Holladay, MD, MSEE, FACS, discusses the optical characteristics of extended depth of focus IOLs, which are newly available in the U.S. and which offer another option in the range of lenses between monofocal IOLs and multifocal IOLs.
Author: Healio ophthalmology
VIDEO: Improvements in DMEK attributed to better OCT technology
KOLOA, Hawaii ― At Hawaiian Eye 2017, Francis W. Price Jr., MD, tells colleagues that improved OCT technologies are enabling improvements in Descemet’s membrane endothelial keratoplasty techniques.
Senate Democrats boycott executive session on HHS, treasury secretary nominations
Democrats on the Senate Finance Committee boycotted the executive session that would decide the nominations of Rep. Tom Price, MD, (R-Ga.) as secretary of HHS and Steven Mnuchin as secretary of the treasury.“I am disappointed that [the Democrats] are boycotting this consideration of Steven Mnuchin to be the secretary of the treasury and Representative Tom Price, one of the members of our Congress, to be secretary of Health and Human Services,” Orrin Hatch (R-Utah), chairman of the Senate Finance Committee, said. “We ought to be proud of [Price] and we (Read more...)
Pharmaceutical executives meet with Trump to discuss affordability, accessibility of prescription drugs
President Donald J. Trump met today with executives from the nation’s leading pharmaceutical companies to discuss strategies to increase U.S. production while reforming regulations that contribute to higher costs.Stephen J. Ubl, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), described the session as “a positive, productive meeting.”
Female ophthalmologists submit fewer Medicare charges than male counterparts
Female ophthalmologists in the United States submit fewer charges to Medicare than their male colleagues, a study found.The retrospective review included Medicare payments made to ophthalmologists for outpatient services from Jan. 1, 2012, to Dec. 31, …
What do the numbers tell us about the iStent?
As a cataract surgeon, my primary concern is managing a patient’s cataract. I want to provide my patient with the best vision and fewest postoperative issues possible. When I finish a case that in my mind went perfect, do I really want to tilt the patient’s head, tilt the microscope and deal with a glaucoma stent?It is easy to convince ourselves that if a patient with concomitant glaucoma is controlled on drops, we should leave well enough alone. But my feeling is I have a responsibility to help these patients (Read more...)
Tacrolimus treats steroid-refractory vernal keratoconjunctivitis
Tacrolimus eye ointment for steroid-refractory vernal keratoconjunctivitis significantly improved symptoms and signs after 12 weeks but did not significantly improve visual acuity, according to a study.The biggest advantage of tacrolimus is that it doe…
Man presents with diplopia and ptosis of left eye
A 36-year-old Hispanic man with no significant medical or ocular history was referred to the Tufts New England Eye Center with complaints of double vision and drooping of his left upper eyelid. Three months before presentation, he presented to an outsi…
VIDEO: Intriguing papers highlighted at Hawaiian Eye
KOLOA, Hawaii ― At Hawaiian Eye 2017, Andrew P. Schachat, MD, highlights intriguing papers published in the 2016 volume of Ophthalmology.
VIDEO: Ophthalmologists invited to partner with Hawaiian Eye Foundation
KOLOA, Hawaii ― At Hawaiian Eye 2017, Darrah Kauhane, MS, CPO, and Hawaiian Eye Foundation vice president and mission director Jeffrey J. Rutgard, MD, extend an invitation to ophthalmologists to partner with the Foundation in its efforts to promote the prevention of blindness worldwide.
VIDEO: Berdahl discusses evolution of sublingual sedation in cataract surgery
KOLOA, Hawaii ― At Hawaiian Eye 2017, John P. Berdahl, MD, discusses the evolution of sublingual sedation and how it presents an opportunity to provide a better patient experience by eliminating the often painful and difficult process of IV insertion before cataract surgery.
VIDEO: New corneal transplantation techniques take ‘center stage’ in development
KOLOA, Hawaii ― At Hawaiian Eye 2017, Thomas “TJ” John, MD, discusses the latest tips and tricks for advanced techniques in cornea transplantation.
Annual ophthalmologic exams can better detect optic gliomas in pediatric patients
An annual ophthalmologic examination and screening for precocious puberty in children diagnosed with neurofibromatosis type 1 is important for early detection of optic gliomas, according to a study. Researchers reviewed medical records of 708 patients …
AMA leads health care coalition calling for reform of prior authorization programs
The AMA, along with 16 other health care organizations, recently called for the reform of insurer pre-approval requirements for medical tests, procedures, devices and drugs because such prior authorization can delay or interrupt medical services, jeopa…
VIDEO: Neurostimulation for dry eye disease on the horizon
KOLOA, Hawaii ― At Hawaiian Eye 2017, John D. Sheppard, MD, MSSc, anticipates the introduction of neurostimulation as a disruptive innovation that will help patients with dry eye manage their disease.
VIDEO: Potential uses for collagen crosslinking explored
KOLOA, Hawaii ― At Hawaiian Eye 2017, Avedro Chief Medical Officer Raj K. Rajpal, MD, talks about the widening scope of potential uses for corneal collagen crosslinking as well as the advancing associated technologies.
WHO nominates three candidates for director-general
The WHO Executive Board narrowed a list of nominees to be its next director-general to three candidates.David N. Nabarro, BM, BCh, of the United Kingdom; Sania Nishtar, PhD, of Pakistan; and Ethiopia’s Tedros Adhanom Ghebreyesus, PhD, will face a vote by WHO member states in May during the World Health Assembly in Geneva. The winner will assume office as the eighth elected director-general on July 1.
Surgical robot successfully removes blood clot in patient with retinal vein occlusion
Blockage from a blood clot causing retinal vein occlusion in a patient was for the first time removed with the help of a surgical robot at the University Hospitals Leuven, Belgium.Operated by Peter Stalmans, MD, PhD, the robot injected ocriplasmin through a 0.03-mm needle into the target vessel. The plasmin enzyme was able to break up and dissolve the blood clot. In a press release, the team of surgeons that carried out the operation called this technique of retinal vein cannulation (RVC) “a revolutionary treatment that addresses the cause of (Read more...)
VIDEO: Analyses show potential cost savings of ROP screening, treatment program
KOLOA, Hawaii ― At Retina 2017, Timothy W. Olsen, MD, discusses the economic impact of implementing a nationalized program of screening and treatment for retinopathy of prematurity.
AMA updates Code of Medical Ethics
The AMA recently published an updated edition of the Code of Medical Ethics after an 8-year modernization project. To help physicians stay current with evolving demands, such as new technologies, changing patient expectations and shifting health care p…